Patients with Peripheral Artery Disease in the COMPASS Trial
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- December 2018
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1103 Clinical Sciences (FoR)
- Aspirin (MeSH)
- Cardiovascular Diseases (MeSH)
- Cardiovascular System & Hematology (Science Metrix)
- Drug Therapy, Combination (MeSH)
- Hemorrhage (MeSH)
- Humans (MeSH)
- Peripheral Arterial Disease (MeSH)
- Platelet Aggregation Inhibitors (MeSH)
- Randomized Controlled Trials as Topic (MeSH)
- Risk Adjustment (MeSH)
- Rivaroxaban (MeSH)
- Secondary Prevention (MeSH)